149 related articles for article (PubMed ID: 37961653)
1. Characterization of an
Schwartz LS; Saxl RL; Stearns T; Trowbridge JJ
bioRxiv; 2023 Nov; ():. PubMed ID: 37961653
[TBL] [Abstract][Full Text] [Related]
2. Oncostatin M: Dual Regulator of the Skeletal and Hematopoietic Systems.
Sims NA; Lévesque JP
Curr Osteoporos Rep; 2024 Feb; 22(1):80-95. PubMed ID: 38198032
[TBL] [Abstract][Full Text] [Related]
3. Targeted disruption of oncostatin M receptor results in altered hematopoiesis.
Tanaka M; Hirabayashi Y; Sekiguchi T; Inoue T; Katsuki M; Miyajima A
Blood; 2003 Nov; 102(9):3154-62. PubMed ID: 12855584
[TBL] [Abstract][Full Text] [Related]
4. Oncostatin M acting via OSMR, augments the actions of IL-1 and TNF in synovial fibroblasts.
Le Goff B; Singbrant S; Tonkin BA; Martin TJ; Romas E; Sims NA; Walsh NC
Cytokine; 2014 Aug; 68(2):101-9. PubMed ID: 24767864
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.
Kausar T; Sharma R; Hasan MR; Saraya A; Chattopadhyay TK; Gupta SD; Ralhan R
Cell Oncol (Dordr); 2011 Jun; 34(3):177-87. PubMed ID: 21394648
[TBL] [Abstract][Full Text] [Related]
6. Conditional deletion of IκBζ in hematopoietic cells promotes functional recovery after spinal cord injury in mice.
Taki N; Kimura A; Shiraishi Y; Maruyama T; Ohmori T; Takeshita K
J Orthop Sci; 2024 May; ():. PubMed ID: 38760245
[TBL] [Abstract][Full Text] [Related]
7. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
[TBL] [Abstract][Full Text] [Related]
8. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
[TBL] [Abstract][Full Text] [Related]
9. Oncostatin M receptor, positively regulated by SP1, promotes gastric cancer growth and metastasis upon treatment with Oncostatin M.
Yu Z; Li Z; Wang C; Pan T; Chang X; Wang X; Zhou Q; Wu X; Li J; Zhang J; Liu B; Zhu Z; Su L
Gastric Cancer; 2019 Sep; 22(5):955-966. PubMed ID: 30778797
[TBL] [Abstract][Full Text] [Related]
10. OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling.
Feng Y; Yuan Y; Xia H; Wang Z; Che Y; Hu Z; Deng J; Li F; Wu Q; Bian Z; Zhou H; Shen D; Tang Q
J Transl Med; 2023 Apr; 21(1):290. PubMed ID: 37120549
[TBL] [Abstract][Full Text] [Related]
11. Oncostatin M and its receptors mRNA regulation in bovine granulosa and luteal cells.
Martins KR; Haas CS; Ferst JG; Rovani MT; Goetten ALF; Duggavathi R; Bordignon V; Portela VVM; Ferreira R; Gonçalves PBD; Gasperin BG; Lucia T
Theriogenology; 2019 Feb; 125():324-330. PubMed ID: 30504073
[TBL] [Abstract][Full Text] [Related]
12. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
Adrian-Segarra JM; Sreenivasan K; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 Dec; 293(52):20181-20199. PubMed ID: 30373773
[TBL] [Abstract][Full Text] [Related]
13. WNT16 is Robustly Increased by Oncostatin M in Mouse Calvarial Osteoblasts and Acts as a Negative Feedback Regulator of Osteoclast Formation Induced by Oncostatin M.
Henning P; Movérare-Skrtic S; Westerlund A; Chaves de Souza PP; Floriano-Marcelino T; Nilsson KH; El Shahawy M; Ohlsson C; Lerner UH
J Inflamm Res; 2021; 14():4723-4741. PubMed ID: 34566421
[TBL] [Abstract][Full Text] [Related]
14. Murine Oncostatin M Has Opposing Effects on the Proliferation of OP9 Bone Marrow Stromal Cells and NIH/3T3 Fibroblasts Signaling through the OSMR.
Jakob L; Müller TA; Rassner M; Kleinfelder H; Veratti P; Mitschke J; Miething C; Oostendorp RAJ; Pfeifer D; Waterhouse M; Duyster J
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769079
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M Plays a Critical Role in Survival after Acute Intestinal Ischemia: Reperfusion Injury.
Young PY; Mueller TF; Sis B; Churchill TA; Khadaroo RG
Surg Infect (Larchmt); 2020 Nov; 21(9):799-806. PubMed ID: 32379547
[No Abstract] [Full Text] [Related]
16. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
[TBL] [Abstract][Full Text] [Related]
17. Oncostatin M receptor regulates osteoblast differentiation via extracellular signal-regulated kinase/autophagy signaling.
Zhou J; Yang J; Dong Y; Shi Y; Zhu E; Yuan H; Li X; Wang B
Stem Cell Res Ther; 2022 Jun; 13(1):278. PubMed ID: 35765036
[TBL] [Abstract][Full Text] [Related]
18. Oncostatin M regulates hematopoietic stem cell (HSC) niches in the bone marrow to restrict HSC mobilization.
Bisht K; McGirr C; Lee SY; Tseng HW; Fleming W; Alexander KA; Matsumoto T; Barbier V; Sims NA; Müller-Newen G; Winkler IG; Bonig H; Lévesque JP
Leukemia; 2022 Feb; 36(2):333-347. PubMed ID: 34518644
[TBL] [Abstract][Full Text] [Related]
19. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
[TBL] [Abstract][Full Text] [Related]
20. Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages.
Zhang X; Li J; Qin JJ; Cheng WL; Zhu X; Gong FH; She Z; Huang Z; Xia H; Li H
J Lipid Res; 2017 May; 58(5):895-906. PubMed ID: 28258089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
